PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsattention deficit disorder with hyperactivity
MeSH D001289 - attention deficit disorder with hyperactivity
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D019958:Attention deficit and disruptive behavior disorders
38 Companies
1 Drug
$
Success rate
D001289: 
Attention deficit disorder with hyperactivity
147 Companies
27 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine dl-aspartate Adderall  1996-02-13   
Atomoxetine Atomoxetine  2017-05-30   
Clonidine Clonidine  1986-07-08   
Amphetamine, Dextroamphetamine, Dextroamphetamine adipate, Amphetamine adipate Delcobese  1982-01-01   
Dextroamphetamine Dexampex  1982-01-01   
Dexmethylphenidate Dexmethylphenidate  2007-01-29   
Amphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine dl-aspartate Dextroamp Saccharate, Amp Aspartate, Dextroamp Amp  2003-09-30   
Guanfacine Guanfacine  2015-06-02   
Imipramine Imipramine  1982-01-01   
Methamphetamine Methampex  1982-01-01   
Methamphetamine Methamphetamine  1982-01-01   
Methylphenidate Methylphenidate  2012-07-19   
Lisdexamfetamine dimesylate Lisdexamfetamine Dimesylate  2023-08-25   
Novast LaboratoriesAmphetamine Amphetamine  2020-08-24   
Clonidine Clonidine  2019-03-05   
Glenmark PharmaceuticalsAmphetamine Amphetamine  2021-01-27   
Atomoxetine Atomoxetine  2017-05-30   
Rising PharmaceuticalsBupropion Bupropion  2010-05-03   
Clonidine Clonidine  1987-06-09   
Imipramine Imipramine Pamoate  2013-06-28   
Methylphenidate Methylphenidate  2016-11-07   
MylanClonidine Clonidine  2010-07-16   
Amphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine dl-aspartate Dextroamp Saccharate, Amp Aspartate, Dextroamp Amp  2015-11-10   
Dextroamphetamine Dextroamphetamine  2016-01-27   
Clonidine Duraclon  1996-10-02   
Guanfacine Guanfacine  2015-06-02   
Methylphenidate Methylphenidate  2022-03-14   
Lisdexamfetamine dimesylate Lisdexamfetamine Dimesylate  2023-08-25   
NATCO PharmaClonidine, Chlorthalidone Clorpres  1987-02-09   
Modafinil Modafinil  2012-07-16   
Johnson & JohnsonMethylphenidate Concerta  2000-08-01 $612 M Q2/24-Q1/25 
GSKDextroamphetamine Dexedrine  1982-01-01   
Bupropion Wellbutrin  1985-12-30   
Bupropion Zyban  1997-05-14   
CiplaBupropion Bupropion  2016-08-26   
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
90%
18/20
Phase 2
50%
24/48
Phase 3
76%
38/50
Approved: 22Overall Success rate: 34%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Dexmethylphenidate,
Methylphenidate,
Methylphenidate hydrochloride,
Pemoline,
Venlafaxine
Mylan
Venlafaxine
Johnson & Johnson
Methylphenidate,
Methylphenidate hydrochloride,
Lisdexamfetamine,
Aspartame,
BAVISANT,
Phenylacetic acid
GSK
Bupropion,
Bupropion hydrochloride
Lupin Research
Bupropion,
Bupropion hydrochloride
Sandoz
Bupropion,
Bupropion hydrochloride,
Imipramine
Boehringer Ingelheim
Chlorthalidone,
Clonidine
Novartis
Methylphenidate,
Methylphenidate hydrochloride,
Phenylacetic acid,
Isoxaflutole
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use